Epigral opens its first R&D Centre in AhmedabadBy November 20, 2023 The R&D centre which is built across 14,374 square metres, costs Rs 30 crore. Epigral, one of India’s leading integrated…
Paraxylene market to expand by 7%By February 19, 2019 The global paraxylene market stood at $33.03 billion in 2015 and is projected to reap an opportunity worth $60.04 billion by the end of 2024.